Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

Benzinga Newsdesk www.benzinga.com Neutral 90.4%

Neg 0% Neu 90.4% Pos 0%

https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03252026_IMNN_Bautz.pdf

Comments

No comments yet. Be the first!